Early recanalization of veins in patients with DVT treated with rivaroxaban: do we need to move from bedside to bench again?
Int Angiol
.
2018 Feb;37(1):1-3.
doi: 10.23736/S0392-9590.17.03894-9.
Epub 2017 Sep 22.
Authors
Eduardo Ramacciotti
1
2
,
Giuliano G Volpiani
3
4
,
Ronaldo Dávila
3
4
,
Valeria C Resende Aguiar
3
,
Flávia M Silveira Magella
3
,
Jawed Fareed
5
Affiliations
1
Hemostasis and Thrombosis Research Laboratories at Loyola University Medical Center, Maywood, IL, USA - eduardoramacciotti@gmail.com.
2
Department of Vascular Surgery, Hospital e Maternidade Dr. Christóvão da Gama, Santo André, SP, Brazil - eduardoramacciotti@gmail.com.
3
Department of Vascular Surgery, Hospital e Maternidade Dr. Christóvão da Gama, Santo André, SP, Brazil.
4
Vascular Surgery, Santa Casa de Sao Paulo School of Medical Sciences, São Paulo, SP, Brazil.
5
Hemostasis and Thrombosis Research Laboratories at Loyola University Medical Center, Maywood, IL, USA.
PMID:
28945062
DOI:
10.23736/S0392-9590.17.03894-9
No abstract available
Publication types
Editorial
MeSH terms
Factor Xa Inhibitors / therapeutic use*
Humans
Rivaroxaban / therapeutic use*
Treatment Outcome
Venous Thrombosis / drug therapy*
Substances
Factor Xa Inhibitors
Rivaroxaban